These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17065223)

  • 1. A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin.
    Nishikawa K; Watanabe M; Kita E; Igai K; Omata K; Yaffe MB; Natori Y
    FASEB J; 2006 Dec; 20(14):2597-9. PubMed ID: 17065223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin].
    Nishikawa K
    Tanpakushitsu Kakusan Koso; 2008 Jan; 53(1):44-51. PubMed ID: 18186302
    [No Abstract]   [Full Text] [Related]  

  • 3. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
    Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions.
    Tsutsuki K; Watanabe-Takahashi M; Takenaka Y; Kita E; Nishikawa K
    Infect Immun; 2013 Jun; 81(6):2133-8. PubMed ID: 23545297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli.
    Nishikawa K
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):239-47. PubMed ID: 21644029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
    Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
    J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane.
    Kato M; Watanabe-Takahashi M; Shimizu E; Nishikawa K
    Appl Environ Microbiol; 2015 Feb; 81(3):1092-100. PubMed ID: 25452283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.
    Mitsui T; Watanabe-Takahashi M; Shimizu E; Zhang B; Funamoto S; Yamasaki S; Nishikawa K
    Infect Immun; 2016 Sep; 84(9):2653-61. PubMed ID: 27382021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNX1 and SNX2 mediate retrograde transport of Shiga toxin.
    Utskarpen A; Slagsvold HH; Dyve AB; Skånland SS; Sandvig K
    Biochem Biophys Res Commun; 2007 Jun; 358(2):566-70. PubMed ID: 17498660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation.
    Nishikawa K; Matsuoka K; Watanabe M; Igai K; Hino K; Hatano K; Yamada A; Abe N; Terunuma D; Kuzuhara H; Natori Y
    J Infect Dis; 2005 Jun; 191(12):2097-105. PubMed ID: 15897996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo.
    Li T; Tu W; Liu Y; Zhou P; Cai K; Li Z; Liu X; Ning N; Huang J; Wang S; Huang J; Wang H
    Sci Rep; 2016 Feb; 6():21837. PubMed ID: 26903273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
    Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
    Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a peptide motif that potently inhibits two functionally distinct subunits of Shiga toxin.
    Watanabe-Takahashi M; Tamada M; Senda M; Hibino M; Shimizu E; Okuta A; Miyazawa A; Senda T; Nishikawa K
    Commun Biol; 2021 May; 4(1):538. PubMed ID: 33972673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytosis and retrograde transport of Shiga toxin.
    Sandvig K; Bergan J; Dyve AB; Skotland T; Torgersen ML
    Toxicon; 2010 Dec; 56(7):1181-5. PubMed ID: 19951719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in Shiga toxin-producing abilities of bovine and human Escherichia coli O157:H7.
    Taylor EV; Shi X; Alam MJ; Peterson G; Narayanan SK; Renter DG; Nagaraja TG
    Zoonoses Public Health; 2011 May; 58(3):185-91. PubMed ID: 20819202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin A subunit mutant of Escherichia coli O157:H7 releases outer membrane vesicles containing the B-pentameric complex.
    Kim SH; Lee SR; Kim KS; Ko A; Kim E; Kim YH; Chang KT
    FEMS Immunol Med Microbiol; 2010 Apr; 58(3):412-20. PubMed ID: 20199568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli.
    Mendes-Ledesma MR; Rocha LB; Bueris V; Krause G; Beutin L; Franzolin MR; Trabulsi LR; Elias WP; Piazza RM
    Microbiol Immunol; 2008 Oct; 52(10):484-91. PubMed ID: 18822082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands.
    Mulvey GL; Marcato P; Kitov PI; Sadowska J; Bundle DR; Armstrong GD
    J Infect Dis; 2003 Feb; 187(4):640-9. PubMed ID: 12599081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative cytotoxicity of Escherichia coli O157:H7 isolates from beef cattle and humans.
    Lefebvre B; Diarra MS; Vincent C; Moisan H; Malouin F
    Foodborne Pathog Dis; 2009 Apr; 6(3):357-64. PubMed ID: 19278343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.